---
schema_version: "secwatch.filing_event.v1"
accession: "0000034782-26-000014"
form_type: "8-K"
ticker: "SRCE"
cik: "0000034782"
company_name: "1ST SOURCE CORP"
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:18:40.043059+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# 1st Source Executive Chairman Murphy reveals cancer recurrence, will work remotely for 9 weeks

## Summary
- Christopher J. Murphy III, Executive Chairman, announces bladder cancer has returned; beginning new chemo protocol.
- He will work remotely for at least the next nine weeks and stay out of public contact.
- Murphy expresses confidence in CEO Andrea Short, President Kevin Murphy, and CFO Brett Bauer to lead the company.
- The company had a strong financial year and has robust 2026 tactical and three-year strategic plans.
- Cancer is manageable but not curable; Murphy remains optimistic and plans to work as much as possible.

## SEC filing metadata
- accession: 0000034782-26-000014
- form_type: 8-K
- ticker: SRCE
- cik: 0000034782
- company_name: 1ST SOURCE CORP
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34782/000003478226000014/0000034782-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34782/000003478226000014/source-20260223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000034782-26-000014
- JSON: https://secwatch.observer/filing/0000034782-26-000014.json
- Plain text: https://secwatch.observer/filing/0000034782-26-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.